fbpx
QQQ
-4.09
344.69
-1.2%
DIA
+ 0.75
336.04
+ 0.22%
SPY
-1.28
414.14
-0.31%
TLT
-0.44
138.92
-0.32%
GLD
-0.73
164.15
-0.45%

Why Biomarin Pharmaceutical's Stock is Down During Today's Session

February 26, 2021 9:54 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Biomarin Pharmaceutical's Stock Price And Volume Action

Biomarin Pharmaceutical (NASDAQ:BMRN) is currently down 7.49% to a price of $78.33. Friday the stock has been traded at a volume of 86.17 thousand, about 7.66% of its recent 30-day volume average of 1.13 million.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Biomarin Pharmaceutical shares are trading lower after the company issued FY21 sales guidance below analyst estimates.

Perspective On Recent Price Action

The moving average price of the stock over the past 50 days was $85.47 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $131.94 and as low as $68.25.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.

Posted-In:

Movers Trading Ideas

Related Articles

12 Health Care Stocks Moving In Monday's Intraday Session

  read more

12 Healthcare Stocks Moving In Thursday's After-Market Session

Gainers read more

68 Biggest Movers From Yesterday

Gainers Blonder Tongue Laboratories, Inc. (NYSE: BDR) shares climbed 77.6% to close at $1.35 on Wednesday after dropping over 4% on Tuesday. Blonder Tongue Laboratories, earlier during the month, reported results for the second quarter. read more

BioMarin Shares Slammed After Hemophilia A Gene Therapy Stumbles At FDA

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) shares were plunging Wednesday after a negative outcome for a binary event. read more